• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Life Science Partners

Consortium invest £16.9m in Atlas Genetics

A consortium, led by Novartis Venture and Consort Medical, has invested £16.9m in diagnostic company Atlas Genetics Ltd.

  • UK / Ireland
  • 20 July 2011
LSP et al. invest €8.1m in Mendor

A consortium, consisting of Life Sciences Partners (LSP), Finnish entrepreneur Risto Siilasmaa, Finnish Industry Investment, Ilmarinen Mutual Pension Insurance Company, Biothom and Finnvera Venture Capital, has participated in a €8.1m series-B funding...

  • Nordics
  • 21 June 2011
Life Sciences Partners launches €250m fund

Life Sciences Partners has launched LSP Life Sciences Fund N.V. with a target of €250m.

  • Benelux
  • 28 April 2011
Ysios et al. invest €18m in Cellerix

Existing investors have invested a further €18m in Spanish biopharma Cellerix, prior to its merger with Belgium-based TiGenix.

  • Southern Europe
  • 09 March 2011
Lundbeckfond Ventures et al. invest €11.4m in Nexstim

A consortium of investors led by Lundbeckfond Ventures has invested €11.4m in Finnish medical equipment company Nexstim.

  • Expansion
  • 28 January 2011
Syntaxin receives £18m investment

Lundbeckfond Ventures, Seventure and Ipsen have taken part in a series-C round of financing for biopharmaceutical company Syntaxin.

  • UK / Ireland
  • 12 November 2010
Consortium set to list Zealand Pharma

A consortium, consisting of Life Sciences Partners and Sunstone Capital among others, has announced its intention to list Zealand Pharma A/S on the NASDAQ OMX Copenhagen.

  • Nordics
  • 04 November 2010
Young woman at graduation ceremony
Strong research bodes bright future for Dutch venture

The Netherlands’ excellence in the fields of ICT and Life Sciences is driving dealflow up and prompting optimism for the future. By Francinia Protti-Alvarez

  • Early-stage
  • 05 February 2010
dna-strain-web
Exits hat-trick proves healthy appetite for life sciences

  • Healthcare
  • 04 February 2010
LSP in €21.7m series B round for Merus

Life Sciences Partners (LSP), Novartis Option Fund, Pfizer and Bay City Capital have co-led a €21.7m series B financing round for biopharmaceutical Merus.

  • Early-stage
  • 29 January 2010
1 2 3
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013